Discussion about this post

User's avatar
Scenarica's avatar

The experimental finding about the 5th tool breaking selection is the most important observation in this piece because it reveals something the paper-based analysis doesnt quite capture. Tool selection failure is fundamentally about interaction effects between descriptions in the same context window. Adding one tool changes the selection dynamics for every other tool simultaneously, which makes this a combinatorial problem rather than a linear one. You cant test tools individually and expect the ensemble to behave. You have to test the full ensemble after every change to any single tool.

The pharmacology parallel is the one that made this click for me in practice. Each drug works individually. Prescribe five together and the interaction effects produce emergent failures that no individual drug test would predict. Agent toolkits have the exact same property, and the field hasnt built the equivalent of a drug interaction database for tool descriptions. Which is why the eval recommendation at the end is right but probably understated. You need regression testing not just against each tool but against the full description matrix, because the failure mode that ships to production is almost never the tool you just added. its the tool that was working fine yesterday whose selection boundary just got quietly eroded by the new neighbour in the context window.

No posts

Ready for more?